Research Funding Opportunities

Placeholder image
Research Funding Opportunities

Damon Runyon Quantitative Biology Fellowship Award Application Deadline: December 1, 2021

 

Computational biologists apply theoretical principles and develop analysis and inference methods to decipher and understand biological systems. They are experts in quantitative approaches, data science and algorithms, while also having in-depth knowledge of complex biological processes. Particularly in cancer biology, there is a growing need for computational biology leaders with expertise and understanding in both quantitative and biological sciences.

Exceptional quantitative scientists experience a strong pull from the technology industry, and may not have a background in biology, so special attention is needed to recruit and train these scientists in biological research. One way to address this area is by having a funding mechanism with a specific emphasis on data science (rather than simply including data scientists as part of an existing award program).

This award program is designed to encourage quantitative scientists (trained in fields such as mathematics, computer science, physics, engineering, or related) to pursue research careers in computational biology under the joint mentorship of leaders in both computational science (“dry lab”) and cancer biology (“wet lab”). By investing in this area, Damon Runyon will bring additional attention to the importance of these specially trained scientists for making meaningful progress in cancer biology.

The award will provide $240,000 over three years in stipend and expense allowance for the award recipient. The application deadline is Wednesday, December 1, 2021.

For more details and application guidelines, go to https://www.damonrunyon.org/for-scientists/application-guidelines/quantitative

If you have any questions, please contact the Award Programs at awards@damonrunyon.org.

 

Damon Runyon Physician-Scientist Training Award Application Deadline: December 1, 2021

 

Physician-scientists who are both clinically trained and expert researchers are essential to the successful translation of scientific discovery into more effective patient therapies. They have the unique capacity to blend their insights from treating patients and working in the laboratory in a way that enables and accelerates medical advances. However, the pipeline of physician-scientists is dwindling. The decline in this vital cadre of cancer researchers is occurring at a time when cancer research holds the greatest promise of improving survival and quality of life among cancer patients. A growing shortage of physician-scientists means that major laboratory research discoveries will progress to patient application ever more slowly. If the shortage continues unabated, some may not reach patient application at all, thus presenting a crisis in cancer.

In an effort to confront the crisis arising from a growing dearth of physician-scientists, Damon Runyon encourages more physicians to pursue research careers through a program designed to recruit outstanding U.S. Specialty Board-eligible physicians (MDs only) into cancer research careers by providing them with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed all of their cancer clinical training.

The goals of the program are to:

• transform these individuals into the highest quality physician-scientists, capable of conducting research that has the potential to transform the diagnosis, treatment and/or prevention of cancer.

• eliminate the financial disincentive to entering this career path.

The award will provide up to $460,000 over four years in financial support for the award recipient. In addition, the Foundation will retire up to $100,000 of medical school debt still owedThe application deadline for the Physician-Scientist Training Award is Wednesday, December 1, 2021.

Detailed information about the award, eligibility criteria, and application guidelines are available on the Foundation’s website: https://www.damonrunyon.org/for-scientists/application-guidelines/physician-scientist

If you have any questions, please contact the Award Programs at awards@damonrunyon.org.

 

NIH Funding Opportunities and Notices

 

General Notices

 

Review of the Accuracy of Grants Information for Fiscal Year 2021
(NOT-OD-21-186)
National Institutes of Health

Notice of Technical Assistance Webinar for Companion Awards for the Clinical and Translational Science Awards (UM1) Career Development and Training and Specialized Innovation Program Opportunities
(NOT-TR-21-035)
National Center for Advancing Translational Sciences

 

Notice of Changes to Funding Opportunities

 

Notice of Correction to RFA-CA-21-055, "Translational and Basic Science Research in Early Lesions: Coordinating and Data Management Center (U24 Clinical Trial Not Allowed)"
(NOT-CA-21-122)
National Cancer Institute

Notice of Extension of Application Due Date for RFA-DK-21-019, National Program for the Career Development Of Physician Scientists in Diabetes Research (Diabetes - Docs) (K12 Clinical Trial Optional)
(NOT-DK-21-030)
National Institute of Diabetes and Digestive and Kidney Diseases

Notice of NINR Participation in PA-21-049, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
(NOT-NR-21-008)
National Institute of Nursing Research

Notice of Change to NOT-NR-21-001: "Notice of Special Interest (NOSI): NINR Priority Areas for Training and Career Development Awards"
(NOT-NR-21-009)
National Institute of Nursing Research

Notice of Early Expiration of PAR-20-316 "NIH Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 - Clinical Trial Optional)"
(NOT-NS-22-029)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Environmental Health Sciences

Notice of NEI, NIA, NIAAA, NIAMS, NIDA and NIDDK's Participation in RFA-NS-22-016 "HEAL Initiative: Interdisciplinary Teams to Elucidate the Mechanisms of Device-Based Pain Relief (RM1 Clinical Trial Optional)"
(NOT-NS-22-031)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Diabetes and Digestive and Kidney Diseases

Notice of Intent to Publish a Funding Opportunity Announcement for SPARC VNS Endpoints from Standardized Parameters (VESPA) (U54 Clinical Trial Required)
(NOT-RM-22-001)
Office of Strategic Coordination (Common Fund)

NOSI: Notice of Special Interest: Resilience and Vulnerability following Acute Heart, Lung, Blood, and Sleep Insults in People with HIV (R01, Clinical Trial Not Allowed)
(NOT-HL-22-002)
National Heart, Lung, and Blood Institute

Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders
(NOT-NS-22-010)
National Institute of Neurological Disorders and Stroke

Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional)
(PAR-21-344)
John E. Fogarty International Center
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Mental Health
Application Receipt Date(s): December 20, 2022

Limited Competition: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)
(PAR-21-346)
National Cancer Institute
Application Receipt Date(s): November 17, 2021

The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional)
(PAR-21-348)
National Cancer Institute
Application Receipt Date(s): December 15, 2023

NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)
(PAR-21-351)
National Institute on Aging
Application Receipt Date(s): February 12, 2022 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)
(PAR-22-021)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.

Role of Astrocytes in Degeneration of the Neurovascular Unit in AD/ADRDs (R01 Clinical Trial Not Allowed)
(PAR-22-037)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): February 04, 2022

Systems Biology for Infectious Diseases (U19 Clinical Trial Not Allowed)
(RFA-AI-21-065)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): January 14, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date

HEAL initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression Without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development) (UG3/UH3 Clinical Trials Not Allowed)
(RFA-HL-22-013)
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
Application Receipt Date(s): December 03, 2021

Advancing Gender Inclusive Excellence (AGIE) Coordinating Center (U54 Clinical Trial Not Allowed)
(RFA-OD-21-010)
Office of Research on Women's Health
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): November 30, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement.

Postdoctoral Research Fellowships in Biology (PRFB)

Available Formats:

HTML: https://www.nsf.gov/pubs/2021/nsf21614/nsf21614.htm?WT.mc_id=USNSF_25&WT.mc_ev=click

PDF: https://www.nsf.gov/pubs/2021/nsf21614/nsf21614.pdf?WT.mc_id=USNSF_25&WT.mc_ev=click